Harvard Bioscience, Inc.
Index- P/E- EPS (ttm)-0.16 Insider Own9.00% Shs Outstand41.22M Perf Week-3.14%
Market Cap143.45M Forward P/E9.41 EPS next Y0.39 Insider Trans2.05% Shs Float36.49M Perf Month3.93%
Income-6.50M PEG- EPS next Q0.06 Inst Own77.60% Short Float4.29% Perf Quarter-40.42%
Sales120.70M P/S1.19 EPS this Y96.50% Inst Trans0.53% Short Ratio5.00 Perf Half Y-48.40%
Book/sh1.85 P/B2.00 EPS next Y28.85% ROA-4.10% Target Price10.00 Perf Year-55.10%
Cash/sh0.14 P/C26.56 EPS next 5Y10.00% ROE-8.20% 52W Range3.25 - 8.75 Perf YTD-47.52%
Dividend- P/FCF- EPS past 5Y43.70% ROI1.50% 52W High-57.71% Beta1.79
Dividend %- Quick Ratio1.10 Sales past 5Y2.60% Gross Margin56.70% 52W Low13.85% ATR0.23
Employees475 Current Ratio2.20 Sales Q/Q6.70% Oper. Margin-3.60% RSI (14)46.80 Volatility5.11% 6.87%
OptionableYes Debt/Eq0.64 EPS Q/Q-892.90% Profit Margin-5.40% Rel Volume0.64 Prev Close3.60
ShortableYes LT Debt/Eq0.60 EarningsMay 04 BMO Payout- Avg Volume313.33K Price3.70
Recom1.70 SMA20-1.27% SMA50-10.36% SMA200-37.95% Volume201,392 Change2.78%
Jan-07-21Upgrade The Benchmark Company Speculative Buy → Buy
Dec-09-20Initiated Northland Capital Outperform $6
Nov-10-20Initiated KeyBanc Capital Markets Overweight $6
Jul-08-19Downgrade Janney Buy → Neutral $2
Jan-24-18Reiterated Janney Buy $5 → $8
Jan-23-18Reiterated The Benchmark Company Buy $6 → $10
Nov-17-16Initiated Singular Research Buy $5.50
Jul-28-15Initiated The Benchmark Company Buy $8
Jun-15-22 08:40AM  
May-29-22 08:46AM  
May-16-22 09:35AM  
May-04-22 08:25AM  
May-03-22 05:25PM  
Apr-26-22 09:00AM  
Apr-21-22 04:05PM  
Apr-19-22 08:26AM  
Mar-08-22 07:00AM  
Feb-21-22 04:30PM  
Feb-18-22 06:17AM  
Feb-03-22 05:38PM  
Dec-20-21 06:00AM  
Nov-05-21 09:43AM  
Nov-03-21 08:25AM  
Oct-27-21 03:03PM  
Oct-18-21 04:50PM  
Sep-30-21 09:32AM  
Aug-25-21 08:13AM  
Aug-05-21 09:05AM  
Jul-29-21 03:05PM  
Jul-20-21 04:30AM  
Jul-19-21 04:45PM  
Jul-12-21 08:49AM  
Jul-02-21 12:00PM  
Jun-30-21 11:07AM  
Jun-05-21 05:48AM  
Jun-03-21 04:04PM  
May-19-21 07:46AM  
May-07-21 09:13AM  
May-06-21 08:25AM  
Apr-21-21 03:08AM  
Apr-19-21 04:55PM  
Mar-16-21 03:35AM  
Mar-10-21 07:23AM  
Feb-18-21 05:24PM  
Feb-14-21 03:13AM  
Jan-15-21 01:03AM  
Dec-23-20 08:29AM  
Dec-22-20 06:05PM  
Dec-11-20 06:00PM  
Dec-10-20 12:40AM  
Nov-16-20 04:35PM  
Nov-10-20 08:40AM  
Nov-05-20 07:00AM  
Oct-20-20 04:45PM  
Oct-05-20 09:57AM  
Sep-16-20 04:30PM  
Aug-06-20 11:01AM  
Aug-05-20 07:00AM  
Jul-20-20 08:30AM  
Jul-05-20 04:30PM  
Jun-26-20 10:12PM  
Jun-12-20 04:43PM  
May-26-20 05:15PM  
May-05-20 09:15AM  
May-01-20 10:11AM  
Apr-28-20 12:33PM  
Apr-23-20 07:01PM  
Apr-16-20 07:06AM  
Apr-06-20 04:39PM  
Mar-23-20 09:00AM  
Mar-06-20 09:57AM  
Feb-28-20 07:48AM  
Feb-26-20 09:36AM  
Feb-21-20 06:16PM  
Feb-20-20 07:55AM  
Feb-11-20 05:15PM  
Jan-15-20 07:00AM  
Dec-30-19 08:29AM  
Dec-18-19 07:52AM  
Dec-13-19 03:45PM  
Dec-10-19 08:56AM  
Nov-29-19 06:33AM  
Nov-21-19 04:45PM  
Nov-19-19 10:20AM  
Nov-05-19 06:15PM  
Nov-04-19 09:28AM  
Nov-01-19 08:15AM  
Oct-31-19 05:10PM  
Oct-29-19 10:33AM  
Oct-22-19 06:31PM  
Oct-21-19 08:45AM  
Oct-17-19 10:34AM  
Oct-07-19 01:40PM  
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green James WChief Executive OfficerJun 15Buy3.7130,000111,3002,301,582Jun 17 04:00 PM
Green James WChief Executive OfficerMay 09Buy3.4010,00034,0002,319,955May 10 05:13 PM
Green James WChief Executive OfficerMay 06Buy3.7830,000113,4002,309,955May 10 05:13 PM
Green James WChief Executive OfficerAug 23Sale8.0248,175386,3642,091,725Aug 25 04:24 PM